Publicaciones (27) Publicaciones de Emilio Siendones Castillo

2019

  1. ADCK2 haploinsufficiency reduces mitochondrial lipid oxidation and causes myopathy associated with CoQ deficiency

    Journal of Clinical Medicine, Vol. 8, Núm. 9

  2. Evaluación continua formativa y formadora mediante una metodología de enseñanza híbrida inductivo-deductiva para estudiantes de farmacología aplicada al grado de nutrición humana y dietética

    Innovación Docente e Investigación en Ciencias de la Salud (Dykinson), pp. 75-86

2018

  1. Cellular and molecular mechanisms of recessive hereditary methaemoglobinaemia type II

    Journal of Clinical Medicine, Vol. 7, Núm. 10

  2. Desarrollo de habiidades metacognitivas mediante evaluaciones formadoras y dirigidas al aprendizaje.

    IV Congreso Virtual Internacional sobre Innovación Pedagógica y Praxis Educativa INNOVAGOGÍA 2018: libro de actas. 20, 21 y 22 de marzo 2018

  3. Desarrollo de habilidades metacognitivas mediante evaluaciones formadoras y dirigidas al aprendizaje

    Experiencias pedagógicas e innovación educativa: aportaciones desde la praxis docente e investigadora (Octaedro), pp. 1895-1903

2016

  1. Cytochrome b5 reductase and the control of lipid metabolism and healthspan

    npj Aging and Mechanisms of Disease, Vol. 2, Núm. 1

  2. RNA-binding proteins regulate cell respiration and coenzyme Q biosynthesis by post-transcriptional regulation of COQ7

    RNA Biology, Vol. 13, Núm. 7, pp. 622-634

2014

  1. Membrane-bound CYB5R3 is a common effector of nutritional and oxidative stress response through FOXO3a and Nrf2

    Antioxidants and Redox Signaling, Vol. 21, Núm. 12, pp. 1708-1725

2010

  1. CYB5R3: A key player in aerobic metabolism and aging?

    Aging, Vol. 2, Núm. 1, pp. 63-68

2009

  1. Cell survival from chemotherapy depends on NF-κB transcriptional up-regulation of coenzyme Q biosynthesis

    PLoS ONE, Vol. 4, Núm. 4

2008

  1. MEK inhibition induces caspases activation, differentiation blockade and PML/RARα degradation in acute promyelocytic leukaemia

    British Journal of Haematology, Vol. 142, Núm. 1, pp. 27-35

2007

  1. Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: A possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors

    Hematological Oncology, Vol. 25, Núm. 1, pp. 30-37

  2. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands

    American Journal of Physiology - Renal Physiology, Vol. 292, Núm. 5

2006

  1. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-κB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway

    Arthritis and Rheumatism, Vol. 54, Núm. 1, pp. 301-311

  2. Antiphospholipid-mediated thrombosis: Interplay between anticardiolipin antibodies and vascular cells

    Clinical and Applied Thrombosis/Hemostasis, Vol. 12, Núm. 1, pp. 41-45

  3. Cyclin D3 expression in primary Ta/TI bladder cancer

    Journal of Pathology, Vol. 209, Núm. 1, pp. 106-113

  4. Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets.

    Proteomics, Vol. 6 Suppl 1

  5. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies

    Leukemia, Vol. 20, Núm. 8, pp. 1331-1340

2005

  1. PGE1 abolishes the mitochondrial-independent cell death pathway induced by D-galactosamine in primary culture of rat hepatocytes

    Journal of Gastroenterology and Hepatology (Australia), Vol. 20, Núm. 1, pp. 108-116

2004

  1. PGE1-induced NO reduces apoptosis by D-galactosamine through attenuation of NF-κB and NOS-2 expression in rat hepatocytes

    Hepatology, Vol. 40, Núm. 6, pp. 1295-1303